Global Enoxaparin Sodium Market Research Report 2023
The global Enoxaparin Sodium market was valued at US$ 3.5 billion in 2022 and is anticipated to reach US$ 5.0 billion by 2029, witnessing a CAGR of 7.13% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Enoxaparin Sodium is estimated to increase from $ 586 million in 2023 to reach $ 840 million by 2029, at a CAGR of 6.21% during the forecast period of 2023 through 2029.
Asia-Pacific market for Enoxaparin Sodium is estimated to increase from $ 630 million in 2023 to reach $ 1.116 million by 2029, at a CAGR of 9.99% during the forecast period of 2023 through 2029.
The major global manufacturers of Enoxaparin Sodium include Sanofi, Techdow (Hepalink), Teva, Nanjing King-friend, Rovi, Fresenius Kabi, Fosun Pharma(Gland Pharma), Amphastar, etc. In 2022, the world's top three vendors accounted for approximately 66% of the revenue.
This report aims to provide a comprehensive presentation of the global market for Enoxaparin Sodium, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enoxaparin Sodium.
The Enoxaparin Sodium market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Enoxaparin Sodium market comprehensively. Regional market sizes, concerning products by Type, by Channel, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Enoxaparin Sodium manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Channel, and by regions.
Fosun Pharma(Gland Pharma)
Chengdu Baiyu Pharmaceutical
Changzhou Qianhong Bio-pharma
Beijing SL Pharmaceutical
Segment by Type
Segment by Channel
Hospital & Clinic
Consumption by Region
Rest of Europe
Middle East & Africa
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Enoxaparin Sodium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Enoxaparin Sodium in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.